Evidence map›Paper›PMID 36891252›Full record

ArticleJournal of Alzheimer's disease reports2023

The Effects of SARS-CoV-2 Infection on the Cognitive Functioning of Patients with Pre-Existing Dementia.

Souvik Dubey, Shambaditya Das, Ritwik Ghosh, Mahua Jana Dubey, Arka Prava Chakraborty, Dipayan Roy, Gautam Das, Ajitava Dutta, Arindam Santra, Samya Sengupta and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of Alzheimer's disease reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
  4. Article
  5. Targeting G9a-miScience · 2025
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Souvik DubeyDepartment of Neuromedicine, Bangur Institute of Neurosciences (BIN), Kolkata, West Bengal, India.
Shambaditya DasDepartment of Neuromedicine, Bangur Institute of Neurosciences (BIN), Kolkata, West Bengal, India.
Ritwik GhoshDepartment of General Medicine, Burdwan Medical College, and Hospital, Burdwan, West Bengal, India.
Mahua Jana DubeyDepartment of Psychiatry, Berhampur Mental Hospital, Berhampur, West Bengal, India.
Arka Prava ChakrabortyDepartment of Neuromedicine, Bangur Institute of Neurosciences (BIN), Kolkata, West Bengal, India.
Dipayan RoyDepartment of Biochemistry, All India Institute of Medical Sciences (AIIMS), Patna, Bihar, India.
Gautam DasDepartment of Neuromedicine, Bangur Institute of Neurosciences (BIN), Kolkata, West Bengal, India.
Ajitava DuttaDepartment of Neuromedicine, Bangur Institute of Neurosciences (BIN), Kolkata, West Bengal, India.
Arindam SantraDepartment of Neuromedicine, Bangur Institute of Neurosciences (BIN), Kolkata, West Bengal, India.
Samya SenguptaDepartment of General Medicine, Apollo Gleneagles Hospital, Kolkata, West Bengal, India.
Julián Benito-LeónDepartment of Neurology, University Hospital "12 de Octubre", Madrid, Spain.
Bangur Institute of Neurosciences · INApollo Gleneagles Hospitals · INBerhampur University · INBurdwan Medical College & Hospital · INIndian Institute of Technology Madras · INUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cognitive postscripts of COVID-19, codenamed as 'cognitive COVID' or 'brain fog,' characterized by multidomain cognitive impairments, are now being reckoned as the most devastating sequelae of COVID-19. However, the impact on the already demented brain has not been studied. Objective: We aimed to assess the cognitive functioning and neuroimaging following SARS-CoV-2 infection in patients with pre-existing dementia. Methods: Fourteen COVID-19 survivors with pre-existing dementia (four with Alzheimer's disease, five with vascular dementia, three with Parkinson's disease dementia, and two with the behavioral variant of frontotemporal dementia) were recruited. All these patients had detailed cognitive and neuroimaging evaluations within three months before suffering from COVID-19 and one year later. Results: Of the 14 patients, ten required hospitalization. All developed or increased white matter hyperintensities that mimicked multiple sclerosis and small vessel disease. There was a significant increase in fatigue ( Conclusion: The rapid progression of dementia, the addition of further impairments/deterioration of cognitive abilities, and the increase or new appearance of white matter lesion burden suggest that previously compromised brains have little defense to withstand a new insult (i.e., 'second hit' like infection/dysregulated immune response, and inflammation). 'Brain fog' is an ambiguous terminology without specific attribution to the spectrum of post-COVID-19 cognitive sequelae. We propose a new codename, i.e. 'FADE-IN MEMORY' (i.e., Fatigue, decreased Fluency, Attention deficit, Depression, Executive dysfunction, slowed INformation processing speed, and subcortical MEMORY impairment).

Indexed as

Cognitive impairmentCOVID-19dementiapost-COVID-19

Identifiers

PMID36891252
PMCPMC9986710
OpenAlexW4319074065

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.